|
|
|
| Interventional treatment options for management of delayed arterial hemorrhage after major hepato-pancreatic-biliary surgery |
| Benedetto Ielpo a , Salvatore Alborino b , Emmanuel Melloul c , Fabio Salvatori b , Quirino Lai d , Massimo Rossi d , Nicolas Demartines c , Salomone Di Saverio e , ∗ |
a Unidad de Cirugía Hepatobiliopancreática, Hospital del Mar, Barcelona, Spain b Interventional Radiology Unit, Macerata Hospital, Macerata, AV4, ASUR Marche, Italy c HBP and Liver Transplant Surgery Unit, Visceral Surgery Dept, CHUV, University of Lausanne, Lausanne, Switzerland d HBP and Liver Transplant Surgery Unit, Policlinico Umberto I, La Sapienza University of Rome, Rome, Italy e General Surgery Unit, San Benedetto del Tronto Hospital, San Benedetto del Tronto, AV5, ASUR Marche, Italy
∗ Corresponding author.
E-mail address: salomone.disaverio@sanita.marche.it (S. Di Saverio). |
|
|
|
|
Abstract Hilar cholangiocarcinoma is a biliary malignancy arising from the perihilar biliary tree, which is associated with poor oncological outcomes due to its aggressive biology, chemo-resistance and insidious onset [1] . As stated by Di Martino et al., the standard of care is radical resection, and during the last decades, there have been great effort s to improve survival of potentially resectable hilar cholangiocarcinoma, with surgery being the treatment associated with longer survival [2] . However, radical resection still represents a challenging operation with high risk of intraoperative and postoperative complications.
|
|
|
|
|
|
|
|
|
2023, Vol. 22 
